Home » Drug Information » FDA-Approved Drugs » 1999
Medical Areas: Pulmonary/Respiratory Diseases
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: 3M Pharmaceuticals
Approval Status: Approved June 1999
Treatment Area: Pulmonary/Respiratory Diseases
The approval of Proventil HFA (albuterol sulfate) Inhalation
Aerosol covers a supplemental new drug application that provides
for the following: lowering the age from 12 years to 4 years and
older for the treatment or prevention of
- bronchospasm with reversible obstructive airway disease
- exercise-induced bronchospasm
